Resveratrol - CAS 501-36-0
Catalog number: B0084-051361
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Resveratrol (also known as SRT-501) is a phytoalexin derived from grapes and other food products with antioxidant and potential chemopreventive activities. Resveratrol induces phase II drug-metabolizing enzymes (anti-initiation activity); mediates anti-inflammatory effects and inhibits cyclooxygenase and hydroperoxidase functions (anti-promotion activity); and induces promyelocytic leukemia cell differentiation (anti-progression activity), thereby exhibiting activities in three major steps of carcinogenesis. This agent may inhibit TNF-induced activation of NF-kappaB in a dose- and time-dependent manner.
Nutritional supplement in health care products.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-051361 20 g $198 In stock
Bulk Inquiry
Brife Description:
trans-Resveratrol; SRT-501; RM1812; CA1201; Resvida; Vineatrol 20M; trans-Resveratrol; Trans-resveratrol; 3,4',5-Trihydroxystilbene; 3,4',5-Stilbenetriol; 3,5,4'-Trihydroxystilbene
Ingredient of health care products.
Canonical SMILES:
Current Developer:
Sirtris Pharmaceuticals
1. Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations
Jessica Walker*, Katharina Schueller, Lisa-Marie Schaefer. Food Funct.,2014, 5,74–84
Resveratrol, a stilbenoid, is commonly found in peanuts, grapes and red wine. It has been identified to possess antioxidant, chemopreventive and anti-inflammatory activities. However, upon digestion and absorption, resveratrol is metabolized by phase II enzymes, resulting mainly in the formation of sulfated and glucuronated metabolites. In human intervention studies, the following metabolites have been identified in the human plasma and urine: resveratrol-3-sulfate (Res-3-sulf, R3S), resveratrol-3,5-disulfate, resveratrol-3,4’-disulfate (Res-disulfates, RDS), resveratrol-4’-sulfate, resveratrol-3-glucuronide (Res-3-gluc, R3G) and resveratrol-4’-glucuronide (Res-4’-gluc, R4’G). After intake of a bolus dose of 85.5 mg per 70 kg body weight of piceid, a resveratrol glucoside, the in 3-position monosulfated metabolite and the disulfated metabolites were the predominant metabolites detected after 6 h in the plasma of the volunteers, reaching a maximum concentration of 1 mM. In addition, after consumption of a high bolus of 5 g resveratrol, resveratrol-3-sulfate was detected as the most abundant metabolite with a concentration of up to 14 mM in the plasma. In the same study, resveratrol sulfates and glucuronides were analyzed in the plasma with half-lives between 3.2 and 11.5 h, and 2.9 to 10.6 h, respectively. Moreover, an uptake of repeated doses of up to 5 g resveratrol per day for 21 days resulted in a maximal plasma concentration of about 13 mM resveratrol-3-sulfate. ncubation times and the concentrations used in in vitro studies focusing on the biological effects of these metabolites should, therefore, not exceed 14 μM.
2. Resveratrol improves fungal ribosylation capacity through a unique mechanism
Guo-Yan Zhao, Jing-Yang Fan, Rui-Hua Jiao,* Ren-Xiang Tan*. RSC Adv.,2015, 5,5657–5663
Resveratrol (3,5,4’-trihydroxy-stilbene) is a phenolic phytochemical that accumulates in many plants, such as peanuts, grapes, blueberries, mulberries and cranberries. The natural phenol has been found to interfere with a variety of signaling pathways in mammal cells to exhibit anti-carcinogenic, anti-aging, anti-inflammatory, anti-diabetic and antioxidant actions. The study of the metabolic fate of resveratrol has determined its ability to be glycosylated into glucuronides in human cells, glucopyranosides in plant cells, or diglucosides by cyclodextrin glucanotransferase and sucrose phosphorylase from Thermoanaerobacter sp. In addition, resveratrol functions as a phytoalexin in response to microbial stresses. The engineering of resveratrol synthaseencoding genes in heterogenous plants such as Solanum lycopersicum and Oryza sativa can increase their resistance against fungal pathogens. These observations, along with the reported fungal glycosylation of stilbenoids, prompted us to use resveratrol as a xenochemical tool to investigate the glycosylating capacity of D. eschscholzii with an intention to obtain unprecedented fungal glycosides. Here, resveratrol is demonstrated to increase the ribosylation capacity of D. eschscholzii through the activation (or up-regulation) of silent (or less active) ribosyltransferase and p-glycoprotein genes, and the rare fungal ribosylation takes place uniquely through an undescribed mechanism using nicotinamide mononucleotide (NMN) as the ribosyl donor. As detailed below, the work reveals a conventionally undetectable ribosylation process that provides direct evidence for the fungal detoxification of phenolic chemicals and access to new ribosides with biological and/or biomedical significance.
3. Theoretical study of complexation of resveratrol with cyclodextrins and cucurbiturils: structure and antioxidative activity
Lilin Lu*, Shufang Zhu, Haijun Zhang*, Faliang Li, Shaowei Zhanga. RSC Adv.,2015, 5, 14114–14122
Over the past decades, considerable efforts have been devoted to study the antioxidative activity of resveratrol. The phenolic OH groups, especially 4’-OH, and the trans conformation, are believed to be responsible for the excellent anti-oxidative activity of resveratrol. Owing to its structural simplicity, resveratrol has aroused great interest in developing novel analogues with improved antioxidative activity. Various resveratrol-oriented analogues have been designed by introducing different substituent groups to aromatic rings of resveratrol, and electron-donating groups were found to be more effective than other substituent groups. Mikulski et al. found that the oligomers, glucosides of resveratrol, and trans-resveratrol-3-O-glucuronide exhibited more excellent anti-oxidative activity than resveratrol. Incorporation of chroman moiety of vitamin E into resveratrol scaffold, replacement of 4’-OH by mercapto group have also been reported to improve the antioxidative activity. In addition, several structural modifications in the stilbene scaffold have also been performed, such as elongation of conjugated chain, N-substituent of carbon–carbon double bond, and development of novel resveratrol analogues with cis-restricted conformation, to enhance the antioxidative capacity significantly.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related COX Products

CAS 530-78-9 Flufenamic acid

Flufenamic acid
(CAS: 530-78-9)

Flufenamic Acid is an anti-inflammatory agent, and also acts as an ion channel modulator.

CAS 92623-83-1 Pravadoline

(CAS: 92623-83-1)

Pravadoline is a COX inhibitor and cannabinoid CB agonist used as an anti-inflammatory and analgesic agent. It inhibits prostaglandin synthesis, and it also sup...

CAS 22204-53-1 Naproxen

(CAS: 22204-53-1)

(S)-Naproxen is a non-selective COX inhibitor. The IC50 values for human recombinant COX-1 and -2 are 0.6-4.8 µM and 2.0-28.4 µM, respectively. It is an anti-in...

CAS 501-36-0 Resveratrol

(CAS: 501-36-0)

Resveratrol (also known as SRT-501) is a phytoalexin derived from grapes and other food products with antioxidant and potential chemopreventive activities. Resv...

CAS 22071-15-4 Ketoprofen

(CAS: 22071-15-4)

Ketoprofen, (RS)2-(3-benzoylphenyl)-propionic acid (chemical formula C16H14O3) is one of the propionic acid class of nonsteroidal anti-inflammatory drugs (NSAID...

CAS 158959-32-1 SC57666

(CAS: 158959-32-1)

A selective COX2 inhibitor (IC50= 26 nM)

CAS 62-44-2 Phenacetin

(CAS: 62-44-2)

Phenacetin is a non-opioid analgesic without anti-inflammatory properties. It is a pain-relieving and fever-reducing drug and was withdrawn from the Canadian ma...

CAS 154355-75-6 COX/5-LO-IN-1

(CAS: 154355-75-6)

A dual inhibitor of cylooxygenase and 5-lipoxygenase

CAS 162011-90-7 Rofecoxib

(CAS: 162011-90-7)

A COX-2 inhibitor( IC50s = 26 nM and > 50 µM in human osteosarcoma cells )

CAS 53-86-1 Indomethacin

(CAS: 53-86-1)

A nonselective COX1 and COX2 inhibitor with IC50 of 0.1 μg/mL and 5 μg/mL, respectively

CAS 198470-84-7 Parecoxib

(CAS: 198470-84-7)

The prodrug Parecoxib as well as its active metabolite val have a specific affinity to the cannabinoid (CB) receptor measured in CB1-expressing HEK 293 cells an...


(CAS: 163133-43-5)

Naproxcinod, a nitro compound, has been found to be a nitric oxide donor as well as a cyclooxygenase inhibitor that was once studied aginast duchenne muscular d...

CAS 74711-43-6 Zaltoprofen

(CAS: 74711-43-6)

An inhibitor of Cox-1 and Cox-2;A nonsteroidal anti-inflammatory drug

CAS 36322-90-4 Piroxicam

(CAS: 36322-90-4)

Piroxicam is a non-selective COX inhibitor with an IC50 of 6 mM.

CAS 74103-06-3 Ketorolac

(CAS: 74103-06-3)

Ketorolac, a non-selective COX inhibitor, is a non-steroidal anti-inflammatory drug. It shows inhibition of eicosanoid formation in HEL cells (COX-1) and LPS-st...

CAS 71109-09-6 Vedaprofen

(CAS: 71109-09-6)

Vedaprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used in veterinary medicine.

CAS 36062-05-2 Hexahydrocurcumin

(CAS: 36062-05-2)

Extract from the rhizomes of Curcuma longa L, shows cytotoxic effect, may prove useful in cancer prevention.

CAS 181695-72-7 Valdecoxib

(CAS: 181695-72-7)

A selective COX-2 inhibitor

CAS 2438-72-4 Bufexamac

(CAS: 2438-72-4)

Bufexamac is a COX inhibitor for IFN-α release with EC50 of 8.9 μM.Bufexamac is a drug used as an anti-inflammatory agent on the skin, as well as rectally. Comm...

CAS 74103-07-4 Ketorolac

(CAS: 74103-07-4)

A non-selective COX inhibitor of COX-1 and COX-2 with IC50 of 1.23 μM and 3.50 μM, respectively

Chemical Structure

CAS 501-36-0 Resveratrol

Quick Inquiry

Verification code

Featured Items